Do I have to reach the highest dose?

No. Labels list more than one maintenance dose for most medicines, and your prescriber chooses with you.

Why doesn’t this show my dates?

On purpose. A date would read like an instruction to move up, and that decision is for you and your prescriber.

Can I track my own dose steps?

Yes, in the Onederland app. It shows each dose you log and when a step changed, so you can share it at your next visit.

GLP-1 Dose Schedule From the Label

How this works

The math

Why medicines step up

Labels start low and go up slowly to reduce the risk of stomach and gut side effects. The starting dose is usually for getting used to the medicine, not for long-term use.¹

A label gives the least time at a step. It doesn’t say you have to move up. If a dose is hard to tolerate, labels tell prescribers to consider a slower pace or a lower dose.¹²

What the label shows

These are adult label tables. Children and adolescents can have different dose limits.

US

Wegovy²

Dose	Minimum time	Role on the label
0.25 mg	4 weeks	Starting dose
0.5 mg	4 weeks	Step
1 mg	4 weeks	Step
1.7 mg	4 weeks	Maintenance
2.4 mg	4 weeks	Maintenance
7.2 mg	Ongoing	Highest dose

The 7.2 mg dose is only for adult weight reduction, after tolerating 2.4 mg for at least 4 weeks and when further weight reduction is clinically indicated. For cardiovascular risk reduction, maintenance is 2.4 mg (recommended) or 1.7 mg weekly. For noncirrhotic MASH with moderate to advanced fibrosis, maintenance is 2.4 mg weekly; 1.7 mg may be used if 2.4 mg is not tolerated.²

Ozempic³

Dose	Minimum time	Role on the label
0.25 mg	4 weeks	Starting dose
0.5 mg	4 weeks	Maintenance
1 mg	4 weeks	Maintenance
2 mg	Ongoing	Highest dose

This label is for type 2 diabetes. These are not weight-loss dose steps.

These are glycemic-control steps. The US label also covers cardiovascular risk reduction in adults with type 2 diabetes and established cardiovascular disease, and kidney and cardiovascular risk reduction in adults with type 2 diabetes and chronic kidney disease. For the kidney indication, maintenance is 1 mg weekly after at least 4 weeks on 0.5 mg.³

Zepbound¹

Dose	Minimum time	Role on the label
2.5 mg	4 weeks	Starting dose
5 mg	4 weeks	Maintenance
7.5 mg	4 weeks	Step
10 mg	4 weeks	Maintenance
12.5 mg	4 weeks	Step
15 mg	Ongoing	Highest dose

The US label lists 5 mg, 10 mg, or 15 mg once weekly as maintenance doses for weight reduction and long-term maintenance. For obstructive sleep apnea, the maintenance doses are 10 mg or 15 mg once weekly. This table does not choose a dose.¹

Mounjaro⁴

Dose	Minimum time	Role on the label
2.5 mg	4 weeks	Starting dose
5 mg	4 weeks	Step
7.5 mg	4 weeks	Step
10 mg	4 weeks	Step
12.5 mg	4 weeks	Step
15 mg	Ongoing	Highest dose

This label is for type 2 diabetes. These are not weight-loss dose steps.

The US label covers glycemic control and cardiovascular risk reduction in eligible adults with type 2 diabetes. Dose increases are based on a need for additional glycemic control; there is no separate cardiovascular dose schedule.⁴

Wegovy pill²

Dose	Minimum time	Role on the label
1.5 mg	30 days	Starting dose
4 mg	30 days	Step
9 mg	30 days	Step
25 mg	Ongoing	Maintenance

The US tablet schedule applies to weight reduction and cardiovascular risk reduction in eligible adults, with 25 mg daily as maintenance. The MASH indication is for the injection.²

Ozempic pill⁵

Dose	Minimum time	Role on the label
1.5 mg	30 days	Starting dose
4 mg	30 days	Maintenance
9 mg	Ongoing	Highest dose

This label is for type 2 diabetes. These are not weight-loss dose steps.

The US tablet label also covers cardiovascular risk reduction in adults with type 2 diabetes at high cardiovascular risk. It uses the same schedule, with increases based on a need for additional glycemic control.⁵

Rybelsus⁵

Dose	Minimum time	Role on the label
3 mg	30 days	Starting dose
7 mg	30 days	Maintenance
14 mg	Ongoing	Highest dose

This label is for type 2 diabetes. These are not weight-loss dose steps.

Foundayo⁶

Dose	Minimum time	Role on the label
0.8 mg	30 days	Starting dose
2.5 mg	30 days	Step
5.5 mg	30 days	Step
9 mg	30 days	Step
14.5 mg	30 days	Step
17.2 mg	Ongoing	Highest dose

EU

Wegovy⁷

Dose	Minimum time	Role on the label
0.25 mg	4 weeks	Starting dose
0.5 mg	4 weeks	Step
1 mg	4 weeks	Step
1.7 mg	4 weeks	Step
2.4 mg	4 weeks	Maintenance
7.2 mg	Ongoing	Maintenance

For adults, the EU label permits the 7.2 mg maintenance dose only when BMI was at least 30 at treatment initiation, after at least 4 weeks on 2.4 mg. This table does not choose a dose.⁷

Ozempic⁸

Dose	Minimum time	Role on the label
0.25 mg	4 weeks	Starting dose
0.5 mg	4 weeks	Maintenance
1 mg	4 weeks	Maintenance
2 mg	Ongoing	Highest dose

This label is for type 2 diabetes. These are not weight-loss dose steps.

Mounjaro⁹

Dose	Minimum time	Role on the label
2.5 mg	4 weeks	Starting dose
5 mg	4 weeks	Maintenance
7.5 mg	4 weeks	Step
10 mg	4 weeks	Maintenance
12.5 mg	4 weeks	Step
15 mg	Ongoing	Maintenance

The EU label covers type 2 diabetes and weight management. The adult schedule is shared, with 5 mg, 10 mg or 15 mg weekly as maintenance doses.⁹

Wegovy pill⁷

Dose	Minimum time	Role on the label
1.5 mg	4 weeks	Starting dose
4 mg	4 weeks	Step
9 mg	4 weeks	Step
25 mg	Ongoing	Maintenance

Rybelsus¹⁰

Label schedule starting at 1.5 mg

Dose	Minimum time	Role on the label
1.5 mg	1 month	Starting dose
4 mg	1 month	Maintenance
9 mg	1 month	Maintenance
25 mg	1 month	Maintenance
50 mg	Ongoing	Maintenance

Label schedule starting at 3 mg

These are separate label schedules, not a milligram-for-milligram conversion. The current EU product information describes the 25 mg and 50 mg tablets as oval.¹⁰

Dose	Minimum time	Role on the label
3 mg	1 month	Starting dose
7 mg	1 month	Maintenance
14 mg	1 month	Maintenance
25 mg	1 month	Maintenance
50 mg	Ongoing	Maintenance

This label is for type 2 diabetes. These are not weight-loss dose steps.

Japan

Wegovy¹¹

Dose	Minimum time	Role on the label
0.25 mg	4 weeks	Starting dose
0.5 mg	4 weeks	Step
1 mg	4 weeks	Step
1.7 mg	4 weeks	Step
2.4 mg	Ongoing	Maintenance

The Japanese label covers obesity and noncirrhotic MASH with moderate or advanced fibrosis. Both use the same adult escalation to 2.4 mg weekly; the dose may be reduced according to the patient’s condition.¹¹

Ozempic¹²

Dose	Minimum time	Role on the label
0.25 mg	4 weeks	Starting dose
0.5 mg	4 weeks	Maintenance
1 mg	Ongoing	Highest dose

This label is for type 2 diabetes. These are not weight-loss dose steps.

Zepbound¹³

Dose	Minimum time	Role on the label
2.5 mg	4 weeks	Starting dose
5 mg	4 weeks	Maintenance
7.5 mg	4 weeks	Step
10 mg	4 weeks	Maintenance
12.5 mg	4 weeks	Step
15 mg	Ongoing	Highest dose

For obesity, the Japanese label describes 10 mg as the usual dose after escalation, with 5 mg or up to 15 mg according to the patient’s condition. The steps here do not choose a dose for you.¹³

For moderate to severe obstructive sleep apnea, the Japanese label uses escalation to 15 mg weekly, with adjustment within 10–15 mg if not tolerated. The obesity dose description above is not the sleep-apnea schedule.¹³

Mounjaro¹⁴

Dose	Minimum time	Role on the label
2.5 mg	4 weeks	Starting dose
5 mg	4 weeks	Maintenance
7.5 mg	4 weeks	Step
10 mg	4 weeks	Step
12.5 mg	4 weeks	Step
15 mg	Ongoing	Highest dose

This label is for type 2 diabetes. These are not weight-loss dose steps.

Rybelsus¹⁵

Dose	Minimum time	Role on the label
3 mg	4 weeks	Starting dose
7 mg	4 weeks	Maintenance
14 mg	Ongoing	Highest dose

This label is for type 2 diabetes. These are not weight-loss dose steps.

Before you act on this

Talk to your prescriber before changing your dose. This page can’t tell you which step is right for you, or when to move.

Always follow your doctor’s or prescriber’s advice and guidance. Talk to your prescriber before changing your dose.

For information only, not medical advice. Verify results with your healthcare provider; Onederland accepts no liability for use of these tools.

Runs on this device. Nothing you type is sent anywhere.
Every figure names its source, below.
Education, not medical advice. Your prescriber comes first.

Sources

Zepbound (tirzepatide) injection, US prescribing information, revised 08/2026. accessdata.fda.gov
Wegovy (semaglutide) injection and tablets, US prescribing information, revised 06/2026. accessdata.fda.gov
Ozempic (semaglutide) injection, US prescribing information, revised 05/2026. accessdata.fda.gov
Mounjaro (tirzepatide) injection, US prescribing information, revised 08/2026. accessdata.fda.gov
Rybelsus and Ozempic (semaglutide) tablets, US prescribing information, revised 01/2026. accessdata.fda.gov
Foundayo (orforglipron) tablets, US prescribing information, revised 07/2026. dailymed.nlm.nih.gov
EU product information for semaglutide for weight management (tablets: summary of product characteristics, section 4.2), updated 21 September 2026. ema.europa.eu
EU product information: injectable semaglutide for type 2 diabetes. ema.europa.eu
EU product information: tirzepatide. ema.europa.eu
EU product information: oral semaglutide for type 2 diabetes. ema.europa.eu
Japanese prescribing information: injectable semaglutide for obesity, June 2026. pmda.go.jp
Japanese patient medicine guide: injectable semaglutide for type 2 diabetes, March 2024. info.pmda.go.jp
Japanese prescribing information: tirzepatide for obesity, September 2026. pmda.go.jp
Japanese prescribing information: tirzepatide for type 2 diabetes. medical.lilly.com
Japanese patient medicine guide: oral semaglutide for type 2 diabetes, March 2024. info.pmda.go.jp

Label sources last checked on October 30, 2026. Onederland summarizes them; your prescriber and the full prescribing information come first.

GLP-1 dose schedule: the steps on each label

Your numbers will appear here

How this works

Why medicines step up